Tenofovir (local routes)

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Growth parameters and prematurity Preterm (< 37 weeks) Sibeko (vaginal gel), 2011 10.44[0.04; 4.71]416not evaluable Maternal consequences Caesarean 0----- Postpartum hemorrhage 0----- Neonatal disorders Fetal distress 0----- Neonatal death (< 28 days of life) Sibeko (vaginal gel), 2011 10.18[0.01; 3.75]316not evaluable Intrauterine deaths Early intrauterine death (< 22 weeks) Sibeko (vaginal gel), 2011 10.54[0.12; 2.38]1022not evaluable Elective/induced termination of pregnancy Sibeko (vaginal gel), 2011 11.47[0.27; 8.09]622not evaluable Late intrauterine deaths (> 22 weeks) Sibeko (vaginal gel), 2011 11.42[0.03; 74.32]-22not evaluable0.0100.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons